quinoxalines has been researched along with vasotocin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolaj, M; Oz, M; Renaud, LP | 1 |
| Cetin, AH; Charlet, A; Eliava, M; Grinevich, V; Hoffmann, LC; Khrulev, S; Knobloch, HS; Osten, P; Schwarz, MK; Seeburg, PH; Stoop, R | 1 |
2 other study(ies) available for quinoxalines and vasotocin
| Article | Year |
|---|---|
Electrophysiological evidence for vasopressin V(1) receptors on neonatal motoneurons, premotor and other ventral horn neurons.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Anterior Horn Cells; Arginine Vasopressin; Bicuculline; Deamino Arginine Vasopressin; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; GABA Antagonists; Glycine Agents; Hemosiderin; Hormone Antagonists; Interneurons; Male; Oxytocin; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Strychnine; Vasotocin | 2001 |
Evoked axonal oxytocin release in the central amygdala attenuates fear response.
Topics: Action Potentials; Amygdala; Analysis of Variance; Animals; Axons; Behavior, Animal; Conditioning, Psychological; Excitatory Amino Acid Antagonists; Fear; Female; Fiber Optic Technology; GABA Antagonists; Gene Expression Regulation; Genetic Vectors; Green Fluorescent Proteins; Hypothalamus; In Vitro Techniques; Inhibition, Psychological; Lactation; Light; Microscopy, Electron, Transmission; Models, Biological; Neurons; Oxytocin; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Picrotoxin; Prosencephalon; Quinoxalines; Rats; Rats, Wistar; Rhodopsin; Time Factors; Vasotocin; Vesicular Glutamate Transport Protein 2 | 2012 |